Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer. The company is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with thepotential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Elevar Therapeutics holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.

Biotechnology

Design

Health Care

Pharmaceutical

Therapeutics

Elevar Therapeutics

Elevar Therapeutics' headquarters in Salt Lake City, UT, United States

Description

People (1)

Jobs (0)

Other offices